These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 23845845)

  • 21. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.
    Kong FM; Ten Haken RK; Schipper MJ; Sullivan MA; Chen M; Lopez C; Kalemkerian GP; Hayman JA
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):324-33. PubMed ID: 16168827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis.
    Urbanic JJ; Turrisi AT; Sharma AK; Silvestri GA; Williams TE; Vanek KN; Sherman CA
    J Thorac Oncol; 2006 Feb; 1(2):112-9. PubMed ID: 17409839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose-rate brachytherapy for small-sized peripherally located lung cancer.
    Imamura F; Ueno K; Kusunoki Y; Uchida J; Yoshimura M; Koizumi M; Yamasaki H; Nishiyama K
    Strahlenther Onkol; 2006 Dec; 182(12):703-7. PubMed ID: 17149576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma.
    Rosenzweig KE; Fox JL; Yorke E; Amols H; Jackson A; Rusch V; Kris MG; Ling CC; Leibel SA
    Cancer; 2005 May; 103(10):2118-27. PubMed ID: 15830346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes.
    Bush DA; Do S; Lum S; Garberoglio C; Mirshahidi H; Patyal B; Grove R; Slater JD
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):501-5. PubMed ID: 25084608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose proton beam therapy for Stage I non-small-cell lung cancer.
    Nihei K; Ogino T; Ishikura S; Nishimura H
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):107-11. PubMed ID: 16458447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
    Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
    Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
    Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
    Timmerman R; McGarry R; Yiannoutsos C; Papiez L; Tudor K; DeLuca J; Ewing M; Abdulrahman R; DesRosiers C; Williams M; Fletcher J
    J Clin Oncol; 2006 Oct; 24(30):4833-9. PubMed ID: 17050868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
    Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer.
    Zhao L; West BT; Hayman JA; Lyons S; Cease K; Kong FM
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):103-10. PubMed ID: 17363189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypofractionated three-dimensional conformal radiation therapy alone for centrally located cT1-3N0 non-small-cell lung cancer.
    Oh D; Ahn YC; Kim B; Pyo H
    J Thorac Oncol; 2013 May; 8(5):624-9. PubMed ID: 23584294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Ciammella P; Franco P; Mantovani C; Borasio P; Scagliotti GV; Ragona R
    Lung Cancer; 2010 Apr; 68(1):72-7. PubMed ID: 19556022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitive radiation therapy for stage I non-small-cell lung carcinoma: institutional experience with contemporary conformal planning.
    Sandhu AP; Messer K; Fuster MM; Ahmad E; Pu M; Bazhenova L; Rose M; Seagren S
    Clin Lung Cancer; 2009 Nov; 10(6):433-7. PubMed ID: 19900862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
    Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):385-90. PubMed ID: 17869017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25.
    Cheung P; Faria S; Ahmed S; Chabot P; Greenland J; Kurien E; Mohamed I; Wright JR; Hollenhorst H; de Metz C; Campbell H; Vu TT; Karvat A; Wai ES; Ung YC; Goss G; Shepherd FA; O'Brien P; Ding K; O'Callaghan C
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25074417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer.
    Iwata H; Murakami M; Demizu Y; Miyawaki D; Terashima K; Niwa Y; Mima M; Akagi T; Hishikawa Y; Shibamoto Y
    Cancer; 2010 May; 116(10):2476-85. PubMed ID: 20225229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.